Plain-English translation of NCT05982795 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Cystic Fibrosis research guide โResearchers are studying how CFTR Modulator Therapy affects the sinuses and nasal health in adults with cystic fibrosis. This medication works by helping the faulty protein in CF work better, and the study wants to see how that change affects the bacteria living in your nose, inflammation levels, and your overall quality of life and ability to smell. By tracking these changes over two years, doctors hope to better understand how this treatment helps people with CF.
Many people with CF struggle with sinus problems, and researchers want to understand whether the newer CF medications are improving the environment inside the nose โ including reducing harmful bacteria and inflammation โ and whether these improvements are connected to how patients feel and their quality of life.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will visit the research center five times over two years (at 0, 6, 12, 18, and 24 months). At each visit, researchers will collect a small sample of mucus from your nose using a gentle swab, test your sense of smell using a simple kit, and ask you to complete several surveys about how your sinuses feel and how CF affects your daily life. The whole process takes a few hours per visit, and all samples are stored safely for laboratory testing.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
United States